Insulin clearance is associated with carotid artery intima-media thickness

Atherosclerosis

Volumn 229, Issue 2, 2013, Pages 453-458

  Marini, Maria A ^a   Frontoni, Simona ^a   Succurro, Elena ^b   Arturi, Franco ^b   Fiorentino, Teresa V ^b   Sciacqua, Angela ^b   Hribal, Marta L ^b   Perticone, Francesco ^b   Sesti, Giorgio ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Carotid artery intima media thickness; Insulin clearance; Non diabetic subjects; Vascular damage

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD PRESSURE; BODY MASS; CAUCASIAN; ECHOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN CLEARANCE; INSULIN SENSITIVITY; MALE; PRIORITY JOURNAL; WAIST CIRCUMFERENCE;

CAROTID ARTERY INTIMA-MEDIA THICKNESS; INSULIN CLEARANCE; NON-DIABETIC SUBJECTS; VASCULAR DAMAGE;

ADULT; BLOOD GLUCOSE; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INTOLERANCE; HUMANS; HYPERINSULINISM; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS; RISK FACTORS;

EID: 84880640561     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.06.011     Document Type: Article

References (39)

1. Bonora E., Kiechl S., Willeit J., Oberhollenzer F., Egger G., Meigs J.B., et al. Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck Study. Diabetes 2004, 53:1782-1789.
2. Weyer C., Bogardus C., Mott D.M., Pratley R.E. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. JClin Invest 1999, 104:787-794.
3. Howard G., O'Leary D.H., Zaccaro D., Haffner S., Rewers M., Hamman R., et al. Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Circulation 1996, 93:1809-1817.
4. Rutter M.K., Meigs J.B., Sullivan L.M., D'Agostino R.B., Wilson P.W. Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study. Diabetes 2005, 54:3252-3257.
5. Reaven G. Role of insulin resistance in human disease. Diabetes 1988, 37:1595-1607.
6. Alberti K.G., Eckel R.H., Grundy S.M., Zimmet P.Z., Cleeman J.I., Donato K.A., et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120:1640-1645.
7. Despres J.P., Lamarche B., Mauriege P., Cantin B., Dagenais G.R., Moorjani S., et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. NEngl J Med 1996, 334:952-957.
8. Folsom A.R., Szklo M., Stevens J., Liao F., Smith R., Eckfeldt J.H. Aprospective study of coronary heart disease in relation to fasting insulin, glucose, and diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care 1997, 20:935-942.
9. Hu G., Qiao Q., Tuomilehto J., Eliasson M., Feskens E.J., Pyorala K. Plasma insulin and cardiovascular mortality in non-diabetic European men and women: a meta-analysis of data from eleven prospective studies. Diabetologia 2004, 47:1245-1256. DECODE Insulin Study Group.
10. Pyorala M., Miettinen H., Laakso M., Pyorala K. Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Circulation 1998, 98:398-404.
11. Ferrara A., Barrett-Connor E.L., Edelstein S.L. Hyperinsulinemia does not increase the risk of fatal cardiovascular disease in elderly men or women without diabetes: the Rancho Bernardo Study, 1984-1991. Am J Epidemiol 1994, 140:857-869.
12. Lindberg O., Tilvis R.S., Stranberg T.E., Valvanne J., Sairanen S., Ehnholm C., et al. Elevated fasting plasma insulin in a general aged population: an innocent companion of cardiovascular diseases. JAm Geriatr Soc 1997, 45:407-412.
13. Lindahl B., Dinesen B., Eliasson M., Røder M., Jansson J.H., Huhtasaari F., et al. High proinsulin concentration precedes acute myocardial infarction in a nondiabetic population. Metabolism 1999, 48:1197-1202.
14. Goodarzi M.O., Cui J., Chen Y.D., Hsueh W.A., Guo X., Rotter J.I. Fasting insulin reflects heterogeneous physiological processes: role of insulin clearance. Am JPhysiol Endocrinol Metab 2011, 301:E402-E408.
15. Bonora E., Zavaroni I., Coscelli C., Butturini U. Decreased hepatic insulin extraction in subjects with mild glucose intolerance. Metabolism 1983, 32:438-446.
16. Faber O.K., Christensen K., Kehlet H., Madsbad S., Binder C. Decreased insulin removal contributes to hyperinsulinemia in obesity. JClin Endocrinol Metab 1981, 53:618-621.
17. Bonora E., Zavaroni I., Bruschi F., Alpi O., Pezzarossa A., Guerra L., et al. Peripheral hyperinsulinemia of simple obesity: pancreatic hypersecretion or impaired insulin metabolism?. JClin Endocrinol Metab 1984, 59:1121-1127.
18. Erdmann J., Mayr M., Oppel U., Sypchenko O., Wagenpfeil S., Schusdziarra V. Weight-dependent differential contribution of insulin secretion and clearance to hyperinsulinemia of obesity. Regul Pept 2009, 152:1-7.
19. Jones C.N., Abbasi F., Carantoni M., Polonsky K.S., Reaven G.M. Roles of insulin resistance and obesity in regulation of plasma insulin concentrations. Am JPhysiol Endocrinol Metab 2000, 278:E501-E508.
20. Lee C.C., Haffner S.M., Wagenknecht L.E., Lorenzo C., Norris J.M., Bergman R.N., et al. Insulin clearance and the incidence of type 2 diabetes in Hispanics and African Americans: the IRAS Family Study. Diabetes Care 2013, 36:901-907.
21. O'Leary D.H., Polak J.F., Kronmal R.A., Manolio T.A., Burke G.L., Wolfson S.K. Carotid artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. NEngl J Med 1999, 340:14-22. Cardiovascular Health Study Collaborative Research Group.
22. Laakso M., Zilinskaite J., Hansen T., Boesgaard T.W., Vänttinen M., Stancáková A., et al. Insulin sensitivity, insulin release and GLP-1 levels in subjects with IFG and/or IGT in the EUGENE2 study. Diabetologia 2008, 51:502-511.
23. Marini M.A., Frontoni S., Mineo D., Bracaglia D., Cardellini M., De Nicolais P., et al. The Arg972variant in insulin receptor substrate-1 is associated with an atherogenic profile in offspring of type 2 diabetic patients. JClin Endocrinol Metab 2003, 88:3368-3371.
24. Cardellini M., Marini M.A., Frontoni S., Hribal M.L., Andreozzi F., Perticone F., et al. Carotid artery intima-media thickness is associated with insulin-mediated glucose disposal in nondiabetic normotensive offspring of type 2 diabetic patients. Am J Physiol Endocrinol Metab 2007, 292:E347-E352.
25. DeFronzo R.A., Tobin J.D., Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol Endocrinol Metab Gastrointest Physiol 1979, 237:E214-E223.
26. Mancia G., De Backer G., Dominiczak A., Cifkova R., Fagard R., Germano G., et al. 2007 Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007, 28:1462-1536.
27. Abdul-Hay S.O., Kang D., McBride M., Li L., Zhao J., Leissring M.A. Deletion of insulin-degrading enzyme elicits antipodal, age-dependent effects on glucose and insulin tolerance. PLoS One 2011, 6:e20818.
28. Mittelman S.D., Van Citters G.W., Kim S.P., Davis D.A., Dea M.K., Hamilton-Wessler M., et al. Longitudinal compensation for fat-induced insulin resistance includes reduced insulin clearance and enhanced beta-cell response. Diabetes 2000, 49:2116-2125.
29. Potenza M.A., Marasciulo F.L., Chieppa D.M., Brigiani G.S., Formoso G., Quon M.J., et al. Insulin resistance in spontaneously hypertensive rats is associated with endothelial dysfunction characterized by imbalance between NO and ET-1 production. Am J Physiol 2005, 289:H813-H822.
30. Madonna R., Pandolfi A., Massaro M., Consoli A., De Caterina R. Insulin enhances vascular cell adhesion molecule-1 expression in human cultured endothelial cells through a pro-atherogenic pathway mediated by p38 mitogen activated protein-kinase. Diabetologia 2004, 47:532-536.
31. Madonna R., De Caterina R. Prolonged exposure to high insulin impairs the endothelial PI3-kinase/Akt/nitric oxide signalling. Thromb Haemost 2009, 101:345-350.
32. Pandolfi A., Iacoviello L., Capani F., Vitacolonna E., Donati M.B., Consoli A. Glucose and insulin independently reduce the fibrinolytic potential of human vascular smooth muscle cells in culture. Diabetologia 1996, 39:1425-1431.
33. Lee C.C., Lorenzo C., Haffner S.M., Wagenknecht L.E., Festa A., Goodarzi M.O., et al. The association of inflammatory and fibrinolytic proteins with 5 year change in insulin clearance: the Insulin Resistance Atherosclerosis Study (IRAS). Diabetologia 2013, 56:112-120.
34. Duckworth W.C., Bennett R.G., Hamel F.G. Insulin degradation: progress and potential. Endocr Rev 1998, 19:608-624.
35. Duckworth W.C., Bennett R.G., Hamel F.G. The significance of intracellular insulin to insulin action. JInvestig Med 1997, 45:20-27.
36. Hribal M.L., D'Alfonso R., Giovannone B., Lauro D., Liu Y.Y., Borboni P., et al. The sulfonylurea glimepiride regulates intracellular routing of the insulin-receptor complexes through their interaction with specific protein kinase C isoforms. Mol Pharmacol 2001, 59:322-330.
37. Sesti G., D'Alfonso R., Vargas Punti M.D., Tullio A.N., Liu Y.Y., Federici M., et al. Delayed intracellular dissociation of the insulin-receptor complex impairsreceptor recycling and insulin processing in cultured EBV-transformed lymphocytes from insulin-resistant subjects. Diabetologia 1996, 39:289-297.
38. Haffner S.M., Stern M.P., Watanabe R.M., Bergman R.N. Relationship of insulin clearance and secretion to insulin sensitivity in non-diabetic Mexican Americans. Eur J Clin Invest 1992, 22:147-153.
39. Liew C.F., Seah E.S., Yeo K.P., Lee K.O., Wise S.D. Lean, nondiabetic Asian Indians have decreased insulin sensitivity and insulin clearance, and raised leptin compared to Caucasians and Chinese subjects. Int J Obes Relat Metab Disord 2003, 27:784-789.